ImmunoPrecise Antibodies Ltd. (IPA)

ImmunoPrecise Antibodies Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	98	34	64	131	187	38
Market Cap Growth	-67.25%	-47.50%	-50.98%	-30.05%	386.87%	-4.92%
Enterprise Value	106	40	61	107	178	40
Last Close Price	2.31	1.28	2.57	5.56	9.76	2.77
PS Ratio	4.00	1.89	4.21	8.66	12.87	3.80
PB Ratio	6.09	1.37	1.51	2.23	4.05	3.54
P/TBV Ratio	9.49	17.29	11.26	7.20	5.35	-
EV/Sales Ratio	6.38	2.23	4.02	7.09	12.22	3.96
Debt / Equity Ratio	0.52	0.40	0.13	0.04	0.06	0.30
Asset Turnover	0.39	0.36	0.24	0.24	0.38	0.51
Inventory Turnover	5.30	5.94	4.95	5.95	6.43	7.54
Quick Ratio	1.99	0.98	2.14	3.59	7.56	0.80
Current Ratio	2.32	1.41	2.84	4.03	8.05	0.97
Return on Equity (ROE)	-124.75%	-59.26%	-39.91%	-25.28%	-20.39%	-29.84%
Return on Assets (ROA)	-14.88%	-12.78%	-18.33%	-13.04%	-8.83%	-9.18%
Return on Capital (ROIC)	-18.07%	-15.63%	-21.96%	-15.12%	-10.40%	-12.61%
Earnings Yield	-30.55%	-58.70%	-30.53%	-9.96%	-3.19%	-9.27%
FCF Yield	-6.56%	-12.19%	-24.51%	-6.55%	-0.88%	-3.47%
Buyback Yield / Dilution	-13.70%	-2.97%	-26.46%	-19.51%	-20.88%	-8.67%

Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q